These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8333408)

  • 1. Inner-city pharmacies: can they meet the OBRA '90 mandates?
    Reutzel TJ; Wilson LA; Mickel M; Lee J; Anderson K; Gray S; Borkowski J; Manasse H; Cooksey J
    Am Pharm; 1993 May; NS33(5):44-51. PubMed ID: 8333408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provision of drug information to patients by pharmacists: the impact of the Omnibus Budget Reconciliation Act of 1990 a decade later.
    Schatz R; Belloto RJ; White DB; Bachmann K
    Am J Ther; 2003; 10(2):93-103. PubMed ID: 12629587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure and function of urban pharmacies: visits to community pharmacies in inner-city Chicago.
    Reutzel TJ; Wilson LA
    Henry Ford Hosp Med J; 1992; 40(1-2):56-61. PubMed ID: 1428979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What you need to know about OBRA '90.
    Martin S
    Am Pharm; 1993 Jan; NS33(1):26-8. PubMed ID: 8430614
    [No Abstract]   [Full Text] [Related]  

  • 5. Pre-OBRA '90 Medicaid survey: how community pharmacy practice is changing.
    Pugh CB
    Am Pharm; 1995 Feb; NS35(2):17-23. PubMed ID: 7900647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The financial impact of OBRA-90 on community pharmacies: an overview.
    Nightengale B; Reeder CE
    Clin Ther; 1993; 15(3):581-92. PubMed ID: 8364950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OBRA '90: the impact on pharmacists and patients.
    Perri M; Kotzan J; Pritchard L; Ozburn W; Francisco G
    Am Pharm; 1995 Feb; NS35(2):24-8, 65. PubMed ID: 7900648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to compliance with OBRA'90 regulations in community pharmacies.
    Barnes JM; Riedlinger JE; McCloskey WW; Montagne M
    Ann Pharmacother; 1996 Oct; 30(10):1101-5. PubMed ID: 8893115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dispensing errors and counseling in community practice.
    Allan EL; Barker KN; Malloy MJ; Heller WM
    Am Pharm; 1995 Dec; NS35(12):25-33. PubMed ID: 8546071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy.
    Valluri S; Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL
    BMC Health Serv Res; 2007 Jul; 7():122. PubMed ID: 17663768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes towards sales and use of over-the-counter drugs in Sweden in a reregulated pharmacy market: a population-based study.
    Hedenrud T; Andersson Sundell K; Martinsson J; Håkonsen H
    Int J Pharm Pract; 2019 Feb; 27(1):17-24. PubMed ID: 29687513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of pharmacies and pharmacists associated with the provision of cognitive services in the community setting.
    Christensen DB; Hansen RW
    J Am Pharm Assoc (Wash); 1999; 39(5):640-9. PubMed ID: 10533345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of OBRA '90 on pharmacists' patient counseling practices.
    Scott DM; Wessels MJ
    J Am Pharm Assoc (Wash); 1997; NS37(4):401-6. PubMed ID: 9519650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of pharmacy participation in Medicaid: implications for enrollee access.
    Adams EK; Gavin N
    Inquiry; 1996-1997 Winter; 33(4):339-51. PubMed ID: 9031650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies.
    Ross-Degnan D; Soumerai SB; Goel PK; Bates J; Makhulo J; Dondi N; Sutoto ; Adi D; Ferraz-Tabor L; Hogan R
    Health Policy Plan; 1996 Sep; 11(3):308-18. PubMed ID: 10160376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ending tobacco sales in pharmacies: A qualitative study.
    Jin Y; Berman M; Klein EG; Foraker RE; Lu B; Ferketich AK
    J Am Pharm Assoc (2003); 2017; 57(6):670-676.e1. PubMed ID: 28823544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of local competition on the willingness of community pharmacies to supply medication therapy management services.
    Brooks JM; Klepser DG; Urmie JM; Farris KB; Doucette WR
    J Health Hum Serv Adm; 2007; 30(1):4-27. PubMed ID: 17557694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial impact of patients enrolled in a medication adherence program at an independent community pharmacy.
    Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S109-S113. PubMed ID: 30006182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fewer Pharmacies In Black And Hispanic/Latino Neighborhoods Compared With White Or Diverse Neighborhoods, 2007-15.
    Guadamuz JS; Wilder JR; Mouslim MC; Zenk SN; Alexander GC; Qato DM
    Health Aff (Millwood); 2021 May; 40(5):802-811. PubMed ID: 33939507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.